Skip to main content

Table 3 Risk for drug resistance among different clinic settings

From: High rates of adherence and treatment success in a public and public-private HIV clinic in India: potential benefits of standardized national care delivery systems

Type of healthcare setting

Unadjusted risk for drug resistance

Adjusted risk adjusted for marital status, barriers of adherence, time on ART a

 

OR

95% CI

p-value

OR

95% CI

p-value

Private

2.66

1.24-5.73

0.012

2.53

1.13-5.66

0.02

Public-private

0.91

0.44-1.90

0.809

1.17

0.51-2.69

0.72

Public

1 (reference category)

1 (reference category)

  1. aFactors that were not significantly associated were gender, residence, education, income, disclosure status, side effects, and regimen switch.